The upcoming Cyprus Presidency of the Council of the EU has asked the EESC to draw up an exploratory opinion aimed at providing insight and recommendation on the establishment of the European centre of clinical excellence for pharmaceuticals, with the view to serve as a unified, evidence-based authority issuing pharmacotherapy recommendations, guidelines, and protocols for a wide range of diseases.
Healthcare professionals and civil society representatives called on policy-makers to introduce a ‘Health check’ for all future policies. Their demand just before the elections to the European Parliament: the ‘Right to Health’ must remain at the top of the EU and national agendas, as citizens demanded at the Conference on the Future of Europe.
Conference on 'The State of Health in the EU', organised by the EESC Civil Society Organisations' Group, in partnership with the Centre Hospitalier Universitaire de Liège and the Hôpital de la Citadelle, in the framework of the Belgian presidency of the Council of the EU, 4 June, Liège (Belgium)
Conference in the framework of the Belgian presidency of the Council of the European Union
Event type
Conference
Location
16 Place du 20-Août
Liège
Belgium
The Civil Society Organisations' Group organised this conference in partnership with the Centre Hospitalier Universitaire de Liège and the Hôpital de la Citadelle.
Our members present their ideas for the future of health policy in the EU
Guest articles by Marc De Paoli (Managing Director, Liège University Hospital), Sylvianne Portugaels (Director-General, Citadelle Hopital) and Martyna Kowacka (Chief Commissioner, Polish Scouting and Guiding Association (ZHP))
Interview with rapporteur Krzysztof Balon on the EESC opinion 'Digitalisation in social security'
Report on our recent #EUelections2024 conference on 'Building Together the EU We Want'
The Consultative Commission on Industrial Change (known by its French acronym of CCMI, Commission Consultative des Mutations Industrielles), is the heir of the European Coal and Steel Community (CECA in French) and joined the EESC in 2002. Since then, the CCMI’s remit does no longer only cover the traditional coal and steel sectors but has been extended to embrace all sectors of industry in both manufacturing and services.
Following the publication of the European Commission's Update to the New Industrial Strategy, the European Economic and Social Committee (EESC) has been carrying out a series of activities to fulfil its role of representing the views of organised civil society. A key event in this process has been a conference held on 17 June 2021, from 2.30 to 6 p.m., on Updated industrial strategy: towards a more resilient and strategically autonomous EU industry.
The Commission proposes a new pharmaceutical strategy for Europe. It is a patient-centred strategy that aims to ensure the quality and safety of medicines, while boosting the sector’s global competitiveness. The EU needs to make sure that patients have access to high-quality, effective and safe medicines. It will foster patient access to innovative and affordable medicines. It will support the competitiveness and innovative capacity of the EU’s pharmaceutical industry.
Download — Tuairim ó CESE: Pharmaceutical strategy
